2022 Q4 Form 10-Q Financial Statement

#000137536522000119 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $1.803B $1.852B
YoY Change 53.8% 79.34%
Cost Of Revenue $1.466B $1.505B
YoY Change 45.32% 68.19%
Gross Profit $337.4M $347.5M
YoY Change 106.07% 151.58%
Gross Profit Margin 18.71% 18.76%
Selling, General & Admin $51.54M $53.17M
YoY Change 9.14% 21.2%
% of Gross Profit 15.27% 15.3%
Research & Development $70.70M $74.24M
YoY Change 7.99% 13.97%
% of Gross Profit 20.95% 21.36%
Depreciation & Amortization $8.649M $8.547M
YoY Change 6.34% 13.24%
% of Gross Profit 2.56% 2.46%
Operating Expenses $122.2M $127.4M
YoY Change 8.47% 16.88%
Operating Profit $215.2M $220.1M
YoY Change 321.52% 655.71%
Interest Expense $1.756M $3.938M
YoY Change 52.7% 389.8%
% of Operating Profit 0.82% 1.79%
Other Income/Expense, Net -$6.335M $8.054M
YoY Change 943.66% 16008.0%
Pretax Income $207.1M $224.2M
YoY Change 320.13% 690.3%
Income Tax $29.60M $38.90M
% Of Pretax Income 14.29% 17.35%
Net Earnings $176.2M $184.4M
YoY Change 320.13% 624.99%
Net Earnings / Revenue 9.77% 9.96%
Basic Earnings Per Share $3.31 $3.51
Diluted Earnings Per Share $3.14 $3.35
COMMON SHARES
Basic Shares Outstanding 52.92M shares 52.35M shares
Diluted Shares Outstanding 56.14M shares 55.02M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $304.6M $238.3M
YoY Change 23.11% -11.77%
Cash & Equivalents $304.6M $238.3M
Short-Term Investments
Other Short-Term Assets $21.89M $169.2M
YoY Change -36.9% 357.54%
Inventory $1.422B $1.736B
Prepaid Expenses $9.507M $7.534M
Receivables $768.2M $736.3M
Other Receivables $133.0M $0.00
Total Short-Term Assets $2.650B $2.880B
YoY Change 15.53% 41.38%
LONG-TERM ASSETS
Property, Plant & Equipment $289.3M $290.8M
YoY Change 3.2% 2.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.197M $4.352M
YoY Change -28.3% -15.68%
Other Assets $37.25M $37.14M
YoY Change 1.39% -0.04%
Total Long-Term Assets $425.4M $421.4M
YoY Change 10.99% 8.12%
TOTAL ASSETS
Total Short-Term Assets $2.650B $2.880B
Total Long-Term Assets $425.4M $421.4M
Total Assets $3.075B $3.301B
YoY Change 14.88% 36.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $560.0M $785.0M
YoY Change -19.45% 39.03%
Accrued Expenses $169.9M $213.5M
YoY Change -0.67% 21.86%
Deferred Revenue $120.5M $185.2M
YoY Change -15.13% 62.93%
Short-Term Debt $0.00 $101.2M
YoY Change -100.0% -56.7%
Long-Term Debt Due $27.87M $101.2M
YoY Change -84.25% -56.7%
Total Short-Term Liabilities $916.9M $1.353B
YoY Change -23.56% 22.87%
LONG-TERM LIABILITIES
Long-Term Debt $142.3M $148.6M
YoY Change 2.33% 229.13%
Other Long-Term Liabilities $37.31M $39.55M
YoY Change -8.13% -13.14%
Total Long-Term Liabilities $179.6M $39.55M
YoY Change -0.03% -56.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $916.9M $1.353B
Total Long-Term Liabilities $179.6M $39.55M
Total Liabilities $1.256B $1.676B
YoY Change -15.68% 29.54%
SHAREHOLDERS EQUITY
Retained Earnings $1.304B $1.127B
YoY Change 79.76% 65.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.819B $1.625B
YoY Change
Total Liabilities & Shareholders Equity $3.075B $3.301B
YoY Change 14.88% 36.04%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $176.2M $184.4M
YoY Change 320.13% 624.99%
Depreciation, Depletion And Amortization $8.649M $8.547M
YoY Change 6.34% 13.24%
Cash From Operating Activities $161.1M $313.6M
YoY Change -403.07% -333.03%
INVESTING ACTIVITIES
Capital Expenditures $9.885M $10.75M
YoY Change -179.69% -0.52%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$9.885M -$10.75M
YoY Change -20.31% -9.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -84.64M -$331.2M
YoY Change -297.24% -279.73%
NET CHANGE
Cash From Operating Activities 161.1M $313.6M
Cash From Investing Activities -9.885M -$10.75M
Cash From Financing Activities -84.64M -$331.2M
Net Change In Cash 66.56M -$29.81M
YoY Change -393.95% -178.92%
FREE CASH FLOW
Cash From Operating Activities $161.1M $313.6M
Capital Expenditures $9.885M $10.75M
Free Cash Flow $151.2M $302.8M
YoY Change -471.07% -308.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Super Micro Computer, Inc.
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001375365
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-33383
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0353939
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
980 Rock Avenue
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
CY2022Q3 dei City Area Code
CityAreaCode
408
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
503-8000
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2022Q3 dei Trading Symbol
TradingSymbol
SMCI
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52922886 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238268000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267397000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
736312000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
834513000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1736055000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1545606000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169245000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158799000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
2879880000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
2806315000 usd
CY2022Q3 us-gaap Equity Method Investments
EquityMethodInvestments
4352000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
5329000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290752000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
89155000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
69929000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37144000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37532000 usd
CY2022Q3 us-gaap Assets
Assets
3301283000 usd
CY2022Q2 us-gaap Assets
Assets
3205077000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
785025000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
655403000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213521000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212419000 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
68411000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
41743000 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
101173000 usd
CY2022Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
449146000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
185225000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
111313000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1353355000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1470024000 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
134625000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
122548000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
148551000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
147618000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39549000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39140000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1676080000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1779330000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
3700000 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52851000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52311000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52851000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52311000 shares
CY2022Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
497183000 usd
CY2022Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
481741000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
514000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
911000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1127339000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
942923000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1625036000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1425575000 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
167000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
172000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1625203000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425747000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3301283000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3205077000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1852130000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1032730000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
1504595000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
894591000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
347535000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
138139000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74243000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65143000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
29363000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21624000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23806000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22244000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
127412000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
109011000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
220123000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
29128000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8054000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
3938000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
804000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
224239000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
28374000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38934000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3325000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-889000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
388000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
184416000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25437000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.51
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52598000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50796000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55017000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52916000 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
184416000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25437000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-397000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-397000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
184019000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25433000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1425747000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8144000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-3716000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11014000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-397000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
184411000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1625203000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1096398000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6018000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-2069000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7015000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
25440000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1132798000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
184416000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25437000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8547000 usd
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7548000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
11014000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
7015000 usd
CY2022Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
233000 usd
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-124000 usd
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
9625000 usd
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
3478000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-889000 usd
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
388000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9203000 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-45000 usd
CY2022Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-19226000 usd
CY2021Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
19000 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
306000 usd
CY2021Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-94855000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5859000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
200074000 usd
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
147087000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11991000 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6109000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
132302000 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-54343000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
26668000 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1532000 usd
CY2022Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
85989000 usd
CY2021Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13115000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8000 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1330000 usd
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-159000 usd
CY2021Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1461000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
313587000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-134571000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10746000 usd
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10802000 usd
CY2022Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
CY2021Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1100000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10746000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11902000 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
79141000 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
269806000 usd
CY2022Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
414737000 usd
CY2021Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
89476000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8144000 usd
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6018000 usd
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3716000 usd
CY2021Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2069000 usd
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-15000 usd
CY2021Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-331183000 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
184262000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1472000 usd
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29813000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37778000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268559000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233449000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238746000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271227000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
4076000 usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
508000 usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27274000 usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2732000 usd
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6599000 usd
CY2021Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13063000 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
750000 usd
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6119000 usd
CY2022Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Supplier RiskCertain materials used by the Company in the manufacturing of its products are available from a limited number of suppliers.Concentration of Credit RiskFinancial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash and cash equivalents, restricted cash, investment in an auction rate security and accounts receivable.
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1852130000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1032730000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1852130000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1032730000 usd
CY2022Q3 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Generally, the payment terms of the Company’s offerings range from 30 to 60 days.
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
233800000 usd
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33500000 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
86000000 usd
CY2022 smci Contract With Customer Liability Increase Decrease For Non Cancellable Non Refundable Advance Consideration Or Cash Consideration
ContractWithCustomerLiabilityIncreaseDecreaseForNonCancellableNonRefundableAdvanceConsiderationOrCashConsideration
69600000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
319800000 usd
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.58
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
184416000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
184416000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25437000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
25437000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52598000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50796000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2419000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2120000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55017000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52916000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.51
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1096811000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1025555000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
333092000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
209576000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
306152000 usd
CY2022Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
310475000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1736055000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
1545606000 usd
CY2022Q3 smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
9600000 usd
CY2021Q3 smci Inventory Write Down Excluding Write Down To Net Realizable Value
InventoryWriteDownExcludingWriteDownToNetRealizableValue
3500000 usd
CY2022Q3 smci Accounts Receivable Vendor Current
AccountsReceivableVendorCurrent
150082000 usd
CY2022Q2 smci Accounts Receivable Vendor Current
AccountsReceivableVendorCurrent
138054000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7534000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5632000 usd
CY2022Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
6113000 usd
CY2022Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
5562000 usd
CY2022Q3 us-gaap Prepaid Taxes
PrepaidTaxes
0 usd
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
2352000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
251000 usd
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
5516000 usd
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6948000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169245000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158799000 usd
CY2022Q3 smci Accounts Receivable Manufacturer Current
AccountsReceivableManufacturerCurrent
120300000 usd
CY2022Q2 smci Accounts Receivable Manufacturer Current
AccountsReceivableManufacturerCurrent
98900000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238268000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
267397000 usd
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
251000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
478000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
911000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238746000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268559000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
464975000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
453730000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
174223000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167758000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290752000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1956000 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
37144000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22497000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23679000 usd
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
7518000 usd
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
6316000 usd
CY2022Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1949000 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2011000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1590000 usd
CY2022Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1590000 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1215000 usd
CY2022Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1069000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
478000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
911000 usd
CY2022Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1897000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
37532000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
48779000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
57736000 usd
CY2022Q3 smci Payable Manufacturer
PayableManufacturer
48579000 usd
CY2022Q2 smci Payable Manufacturer
PayableManufacturer
41125000 usd
CY2022Q3 smci Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
35099000 usd
CY2022Q2 smci Accrued Customer Deposits Current
AccruedCustomerDepositsCurrent
30421000 usd
CY2022Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
18250000 usd
CY2022Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
18250000 usd
CY2022Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9722000 usd
CY2022Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
8757000 usd
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8540000 usd
CY2022Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9073000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6960000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7139000 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3130000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4281000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34461000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35637000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
213521000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212419000 usd
CY2021Q2 smci Performance Bonus Liability Tranche Two
PerformanceBonusLiabilityTrancheTwo
4000000 usd
CY2021Q2 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
3600000 usd
CY2021Q3 smci Reduced Payment For Performance Bonus Tranche One
ReducedPaymentForPerformanceBonusTrancheOne
2000000 usd
CY2021Q2 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
3600000 usd
CY2021Q3 smci Performance Bonus Liability Tranche One
PerformanceBonusLiabilityTrancheOne
2000000 usd
CY2021Q3 smci Benefit From Performance Bonus Adjustment Tranche One
BenefitFromPerformanceBonusAdjustmentTrancheOne
1600000 usd
CY2022Q3 smci Bonus Compensation Expense
BonusCompensationExpense
0 usd
CY2021Q3 smci Bonus Compensation Expense
BonusCompensationExpense
1600000 usd
CY2022Q3 smci Accrued Unrecognized Tax Benefits Including Related Interestsand Penalties Noncurrent
AccruedUnrecognizedTaxBenefitsIncludingRelatedInterestsandPenaltiesNoncurrent
19686000 usd
CY2022Q2 smci Accrued Unrecognized Tax Benefits Including Related Interestsand Penalties Noncurrent
AccruedUnrecognizedTaxBenefitsIncludingRelatedInterestsandPenaltiesNoncurrent
18866000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15218000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16661000 usd
CY2022Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
4163000 usd
CY2022Q2 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
3064000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
482000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
549000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39549000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
39140000 usd
CY2021Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2701000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
41700000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12136000 usd
CY2021Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12863000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
8617000 usd
CY2021Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6386000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8473000 usd
CY2021Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7199000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
423000 usd
CY2021Q3 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
183000 usd
CY2022Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12703000 usd
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12233000 usd
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8540000 usd
CY2021Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9532000 usd
CY2022Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
4163000 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1200000 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
1200000 usd
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
249724000 usd
CY2022Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
596764000 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
101173000 usd
CY2022Q2 smci Short Term Debt And Long Term Debt Current Maturities
ShortTermDebtAndLongTermDebtCurrentMaturities
449146000 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
148551000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
147618000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2038000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23900000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
94631000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
37660000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
41491000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
41491000 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
18025000 usd
CY2022Q3 smci Long Term Debt Maturities Repayments Of Principal In After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInAfterYearFour
16426000 usd
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
249724000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2110000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2182000 usd
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2205000 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
750000 usd
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6119000 usd
CY2021Q3 us-gaap Variable Lease Payment
VariableLeasePayment
0 usd
CY2022Q3 us-gaap Variable Lease Payment
VariableLeasePayment
0 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.030
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5828000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6664000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6252000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2542000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1563000 usd
CY2022Q3 smci Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
535000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
23384000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1206000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
22178000 usd
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
200000000 usd
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11014000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7015000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1339000 usd
CY2021Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1888000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
9675000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
5127000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4311416 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.99
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
123750 shares
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
55.67
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
405226 shares
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
20.10
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9238 shares
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
26.61
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4020702 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.79
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M7D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2373832 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
24.87
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M10D
CY2020Q1 smci Share Based Compensation Arrangement By Share Based Payment Award Number Of Tranches
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfTranches
2 tranche
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38900000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3300000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.174
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.117
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3200000 usd
CY2022Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
3000000 usd
CY2018Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 claim
CY2022Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
18250000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
512300000 usd
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
290752000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
285972000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001375365-22-000119-index-headers.html Edgar Link pending
0001375365-22-000119-index.html Edgar Link pending
0001375365-22-000119.txt Edgar Link pending
0001375365-22-000119-xbrl.zip Edgar Link pending
ctbcagreementforindividu.htm Edgar Link pending
ctbcagreementforindividu001.jpg Edgar Link pending
ctbcagreementforindividu002.jpg Edgar Link pending
ctbcagreementforindividu003.jpg Edgar Link pending
ctbcagreementforindividu004.jpg Edgar Link pending
ctbcagreementforindividu005.jpg Edgar Link pending
ctbcagreementforindividu006.jpg Edgar Link pending
ctbcagreementforindividu007.jpg Edgar Link pending
ctbcagreementforindividu008.jpg Edgar Link pending
ctbcagreementforindividu009.jpg Edgar Link pending
ctbcagreementforindividu010.jpg Edgar Link pending
ctbcagreementforindividu011.jpg Edgar Link pending
ctbcagreementforindividu012.jpg Edgar Link pending
ctbcagreementforindividu013.jpg Edgar Link pending
ctbcagreementforindividu014.jpg Edgar Link pending
ctbcagreementforindividu015.jpg Edgar Link pending
ctbcagreementforindividu016.jpg Edgar Link pending
ctbcagreementforindividu017.jpg Edgar Link pending
ctbcagreementforindividu018.jpg Edgar Link pending
ctbcagreementforindividu019.jpg Edgar Link pending
ctbcagreementforindividu020.jpg Edgar Link pending
ctbcagreementforindividu021.jpg Edgar Link pending
ctbcagreementforindividu022.jpg Edgar Link pending
ctbcagreementforindividu023.jpg Edgar Link pending
ctbcagreementforindividu024.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
secondamendmenttoloanagr.htm Edgar Link pending
secondamendmenttoloanagr001.jpg Edgar Link pending
secondamendmenttoloanagr002.jpg Edgar Link pending
secondamendmenttoloanagr003.jpg Edgar Link pending
Show.js Edgar Link pending
smci-20220930.htm Edgar Link pending
smci-20220930.xsd Edgar Link pending
smci-20220930_g1.jpg Edgar Link pending
smci-ex311_20220930x10q.htm Edgar Link pending
smci-ex312_20220930x10q.htm Edgar Link pending
smci-ex321_20220930x10q.htm Edgar Link pending
smci-ex322_20220930x10q.htm Edgar Link pending
smci-20220930_cal.xml Edgar Link unprocessable
smci-20220930_def.xml Edgar Link unprocessable
smci-20220930_pre.xml Edgar Link unprocessable
smci-20220930_lab.xml Edgar Link unprocessable
smci-20220930_htm.xml Edgar Link completed